Affiance Financial’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$3.8K 434
2022
Q4
$3.8K Buy
+100
New +$3.8K ﹤0.01% 351